Billiontoone Inc (BLLN)

NASD · Healthcare · Diagnostics & Research · USA

Billiontoone Inc is a mid cap company (market value between $2 billion and $10 billion) in the Diagnostics & Research industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Billiontoone Inc stock.

Our verdict on BLLN

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.

ETFs with the most weight in BLLN

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Diagnostics & Research

All 44 Diagnostics & Research stocks

Cheaper than BLLN in Diagnostics & Research

23 more in this industry show a wider margin of safety.

Is BLLN undervalued or overvalued?

We do not publish a verdict on BLLN yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of BLLN?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.